Research Article

Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus

Table 1

Characteristics of the study participants ().

Mean ± SD or number (%)

Age, year
Education, year
Disease duration, year
SLEDAI-2K (median 2)
SLEDAI-2K ≥ 616 (20.5)
SDI (median 0)
SDI ≥ 125 (32)
Comorbidities
 Hypertension19 (24.3)
 Diabetes2 (2.6)
 Kidney disease27 (34.6)
 Other rheumatologic diseases11 (14.1)

SLEDAI-2K: Systemic Lupus Erythematosus Disease Activity Index 2000; SDI: Systemic Lupus International Collaborative Clinics/American College of Rheumatology Damage Index.